Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
30 participants
INTERVENTIONAL
2005-06-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Somatosensory Processing in Depression
NCT00386893
Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
NCT00183677
Functional Neuroimaging in Depression
NCT00343070
The Effects of Increased Central Serotonergic Activity on Information Processing
NCT00206934
A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram
NCT01638689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
β-CIT-SPECT, Neurophysiology
β-CIT-SPECT scans and EEG recordings, two assessments each
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for pharmacological treatment
Exclusion Criteria
* Neurological or severe somatic disorders
* Occupational exposition to radiation \>15 mSv per year
* Women during pregnancy or lactation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
H. Lundbeck A/S
INDUSTRY
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Munich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Oliver Pogarell, MD
Role: PRINCIPAL_INVESTIGATOR
Dept. of Psychiatry, University of Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Depts. of Psychiatry and Nuclear Medicine, Ludwig-Maximilians-University of Munich
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK287/98
Identifier Type: -
Identifier Source: secondary_id
ESCIT-SPECT-Pogarell
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.